Cholic Acid-Based Antimicrobial Peptide Mimics as Antibacterial Agents

Area of Science:

• Medicinal Chemistry
• Antimicrobial Drug Discovery
• Molecular Biology

Background:

• Antibiotic resistance poses a significant global health threat, necessitating the development of new antibacterial agents.
• Cholic acid-derived small molecules are emerging as promising antimicrobial peptide mimics.
• There is an urgent need for novel therapeutic strategies against drug-resistant bacterial infections.

Purpose of the Study:

• To design, synthesize, and evaluate novel cholic acid-based small molecular antimicrobial peptide mimics.
• To investigate the structure-activity relationships of these novel compounds against various bacterial strains.
• To explore the mechanism of action of the most potent analogues.

Main Methods:

• Synthesis of cholic acid analogues with varying hydrophobic moieties and amino acid substitutions.
• Antimicrobial activity testing against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria.
• Structure-activity relationship analysis to identify key structural features for potency.
• Bacterial membrane depolarization assays to elucidate the mechanism of action.

Main Results:

• Cholic acid analogues with a tryptophan moiety and a minimum +2 charge exhibited significant antibacterial activity.
• Analogues with lysine-like residues demonstrated high potency against Staphylococcus aureus.
• Di-substituted analogues were effective against both Gram-positive and Gram-negative bacteria.
• Compounds 17c and 17d were identified as the most potent, causing bacterial membrane depolarization.

Conclusions:

• Cholic acid-based peptide mimics represent a viable new class of antimicrobial agents.
• Specific structural features, including tryptophan and positive charge, are crucial for potent antibacterial activity.
• These compounds act by disrupting bacterial membranes, indicating potential as antimicrobial pore-forming agents.